Oral Presentations

Hellriegel B , Daumer M , Neiß A (2003): Analysing the course of multiple sclerosis with segmented regressin models, Discussion paper 355, LMU Munich.

Skinner CJ , Humphreys K (1999): Weibull Regression for Lifetimes Measured with Error. Lifetime Data Analysis; 5: 23-37.

Kapeller P , McLean MA , Griffin CM et al. J Neurol. 2001; 248: 131-138

Wylezinska M , Cifelli A , Jezzard P , Palace J , Alecci M , Matthews PM. Neurology2003; 60: 1949-1954

Paulesu E , Perani D , Fazio F , Comi G , Pozzilli C , Martinelli U. Neuroimage1996; 4: 87-96

Boringa JB , Lazeron RHC , Reuling IEW et al. Mult Scler. 2001; 7: 263-267

Marie RM , Defer GL: Memory and executive functions in multiple sclerosis: preliminary findings with a cognitive battery. Rev Neurol (Paris)2001; 157: 402-408.

Ritvo PG , Fisher JS , Miller DM , Andrews H , Paty DW , LaRocca NG (1997). MSQLI. Multiple sclerosis quality of life inventory. New York: National Multiple Sclerosis Society.

Craig J , Young CA , Ennis M , Baker G , Boggild M. `A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment'JNNP; 2003; 74; 1225-1230.

Frederiksen JL , Larsson HBWL , Olesen J , Stigsby B. MRI, VEP, SEP and biothesiometry suggest monosymptomatic acute optic neuritis to be a first manifestation af multiple sclerosis. Acta Neurologica Scandinavia1991; 83: 343-350.

Frederiksen JL , Petrera J , Larsson HBW , Stigsby B , Olesen J. Serial MRI, VEP, SEP and biothesiometry in acute optic neuritis: value of baseline results to predict the development of new lesions at one year follow up. Acta Neurologica Scandinavia1996; 93: 246-252.

Poser CM , Paty DW , Scheinberg L , et al. New diagnostic criteria for multiple sclerosis: guide lines for research protocols. Ann Neurol1983; 13: 227-231.

Das A and Puvanendran K. Syringomyelia and complex regional pain syndrome as complications of multiple sclerosis. Arch Neurol1999; 56: 1021-1024

Pelletier J , Habib M , Lyon-Caen O , Salamon G , Poncet M , Khalil R. Functional and magnetic resonance imaging correlates of collosal involvement in multiple sclerosis. Arch Neurol1993; 50: 1077-1082.

Barkhof F , Elton M , Lindeboom J , Tas MW , Schmidt WF , Hommes OR et al. Functional atrophy in relapsing-remitting multiple sclerosis pateints. A preliminary MRI study. J Neurol1998; 245: 153-158.

Leocani L , Locatelli T , Martinelli V , Rovaris M , Falautano M , Filippi M et al. Electroencephalographic coherence analysis in multiple sclerosis: correlation with clinical, neuropsychological, and MRI findings. J Neurol Neurosurg Psychiatry2000; 69: 192-198.

Boroojerdi B , Hungs M , Mull M , Topper R , Noth J. Interhemispheric inhibition in patients with multiple sclerosis. Electroencephalogr Clin Neurophysiol1998; 109: 230-237.

Venkatesan R , Lin W , Haacke EM. Accurate determination of spin-density and T1 in the presence of RF-field inhomogeneities and flip-angle miscalibration. Magn Reson Med1998; 40: 592-602.

FSL website: http://www.fmrib.ox.ac.uk/fsl/

Parry A , Clare S , Jenkinson M , Smith S , Palace J , Matthews PM. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis. J Neurol2002; 249: 1279-1286.

Srinivasan R , Henry R , Pelletier D , Nelson SA. Standardized, reproducible, high resolution global measurements of T1 relaxation metrics in cases of multiple sclerosis. AJNR2003; 24: 58-67.

Tourbah A , Stievenart JL , Abanou A , Fontaine B , Cabanis EA , Lyon-Caen O. Correlating multiple MRI parameters with clinical features: an attempt to define a new strategy in multiple sclerosis. Neuroradiology2001 Sep; 43(9): 712-720.

Freedman MS , Patry DG , Grand'Maison F , Myles ML , Paty DW , Selchen DH. Treatment optimization in multiple sclerosis. Can J Neurol Sci2004; 31: 157-168.

Jacob A , McCoy K , Boggild M. Inducing and maintaing remission in aggressive relapsing-remitting multiple sclerosis: experience with sequential treatment with Mitoantrone and Glatiramer Acetate. Multiple Sclerosis2003; 9: S18-S18

Pryce G , O'Neill JK , Amor et al. Re-induction of tolerance in established autoimmnue disease: a strategy for the treatment of multiple sclerosis. Multiple Sclerosis2002; 8: S15-S15

Dos Reis GA , Nobrega AF , Persechini PM. Stage specific distinctions in potassium channel blockers control of T-lymphocyte activation. Int J Immunopharmacol1988; 10: 217-226.

Strauss U , Schubert R , Jung S , Mix E. K+ currents of encephalitogenic memory T cells decrease with encephalitogenicity while interlukin-2 (IL-2) receptor expression remains stable during IL-2 dependent cell expansion. Receptors Channels1998; 6: 73-87.

Chandy KG , DeCoursey TE , Cahalan MD , McLaughlin C , Gupta S. Voltage-gated potassium channels are required for human T lymphocyte activation. J Exp Med1984; 160: 369-385.

Gupta S. Autologous mixed-lymphocyte reaction in man. XVII. In vitro effect of ion channel-blocking agents on the autologous mixed-lymphocyte response. Cell Immunol1987; 104: 290-295.

Weir MR , Gomolka D , Peppler R , Handwerger BS. Mechanisms responsible for inhibition of lymphocyte activation by agents which block membrane calcium or potassium channels. Transplant Proc1993; 25: 605-609.

Beeton C , Wulff H , Barbaria J , Clot-Faybesse O , Pennington M , Bernard D et al. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Nat Acad Sci2001; 98: 13942-13947.

Wulff H , Calabresi PA , Allie R , Yu S , Pennington M , Beeton C et al. The voltage-gated Kv1.3 K(+) channel effector memory T cells as new target for MS. J Clin Invest2003; 111: 1703-1713.

Nauta JJP , Thompson AJ , Barkhof F , Miller DH. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients; statistical power of patient groups and crossover designs. J Neurol Sci1994; 122: 6-14.

Sormani, MP , Bruzzi P , Miller DH , Gasperini C , Barkhof F , Filippi M. Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials. J Neurol Sci1999; 163: 74-80.

Tubridy N , Ader HS , Barkhof F , Thompson AJ , Miller DH. Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo conrolled parallel groups. J Neurol Neurosurg Psych1998; 64: 50-55.

Freal E , Kraft GH , Coryell JK. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehab1984; 65: 135-139.

Ward N , Winters S. Results of a fatigue management program in multiple sclerosis. British Journal of Nursing2003; 12(18): 1075-1080.

Mathiowetz V , Matuska KM , Murphy ME. Efficacy of an energy conservation course for persons with multiple sclerosis. Arch Phys Med Rehab2001; 82: 449-456.

Kirkham APS , Shah NC , Knight SL , Shah PJR , Craggs MD. The acute effects of continuous and conditional neuromodulation on the bladder in spinal cord injury. Spinal Cord2001; 39: 420-428.

Dalmose AL , Rijkhoff NJ , Kirkeby HJ , Nohr M , Sinkjaer T , Djurhuus JC. Electrical Stimulation on the dorsal penile/clitoral nerve as treatment to increase bladder capacity in spinal cord injured patients. Neurourol Urodyn2003; 22: 130-137.